GV and WuXi NextCode both returned to back a $68m round for DNANexus, bringing the biomedical informatics platform’s total funding to approximately $173m.
US-based medical data storage platform developer DNAnexus closed a $68m funding round yesterday featuring GV, a corporate venturing subsidiary of technology conglomerate Alphabet, and genomic information supplier WuXi NextCode.
Foresite Capital, TPG Biotech and Claremont Creek Ventures and Innovatus Capital Partners also participated in the round, which included an undisclosed amount of debt financing from Innovatus.
Founded in 2009, DNAnexus has created a cloud-based DNA sequence data analytics and management platform that allows researchers to analyse vast amounts of data…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
